64.15
price up icon1.41%   0.89
after-market Dopo l'orario di chiusura: 64.15
loading
Precedente Chiudi:
$63.26
Aprire:
$64.06
Volume 24 ore:
254.73K
Relative Volume:
0.23
Capitalizzazione di mercato:
$4.44B
Reddito:
$35.93M
Utile/perdita netta:
$-244.56M
Rapporto P/E:
-16.24
EPS:
-3.95
Flusso di cassa netto:
$-157.31M
1 W Prestazione:
+13.53%
1M Prestazione:
+21.63%
6M Prestazione:
+56.04%
1 anno Prestazione:
+15.54%
Intervallo 1D:
Value
$63.95
$64.82
Intervallo di 1 settimana:
Value
$56.91
$64.82
Portata 52W:
Value
$33.19
$64.82

Merus N V Stock (MRUS) Company Profile

Name
Nome
Merus N V
Name
Telefono
31 030 253 8800
Name
Indirizzo
YALELAAN 62, 3584 CM UTRECHT
Name
Dipendente
260
Name
Cinguettio
@MerusNV
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
MRUS's Discussions on Twitter

Confronta MRUS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MRUS
Merus N V
64.15 4.71B 35.93M -244.56M -157.31M -3.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Merus N V Stock (MRUS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-13 Iniziato Piper Sandler Overweight
2025-02-07 Iniziato Wells Fargo Overweight
2024-11-21 Iniziato Goldman Buy
2024-10-24 Iniziato UBS Buy
2024-03-28 Iniziato Truist Buy
2024-03-04 Reiterato Needham Buy
2023-11-02 Iniziato Canaccord Genuity Buy
2023-08-21 Iniziato TD Cowen Outperform
2022-08-02 Iniziato Stifel Buy
2022-02-11 Iniziato BMO Capital Markets Outperform
2022-02-10 Iniziato Needham Buy
2021-11-17 Ripresa Guggenheim Buy
2021-06-07 Aggiornamento Citigroup Neutral → Buy
2021-04-08 Iniziato William Blair Outperform
2021-03-16 Iniziato SVB Leerink Outperform
2020-06-26 Iniziato H.C. Wainwright Buy
2020-05-27 Downgrade RBC Capital Mkts Outperform → Sector Perform
2019-11-20 Ripresa Guggenheim Buy
2019-06-28 Iniziato ROTH Capital Buy
2019-04-12 Ripresa Guggenheim Buy
2019-04-03 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2019-03-27 Iniziato Berenberg Buy
2018-01-02 Downgrade RBC Capital Mkts Outperform → Sector Perform
2017-09-15 Iniziato RBC Capital Mkts Outperform
2017-03-21 Downgrade Citigroup Buy → Neutral
2016-12-22 Aggiornamento Citigroup Neutral → Buy
2016-11-07 Downgrade Citigroup Buy → Neutral
2016-06-13 Iniziato Citigroup Buy
2016-06-13 Iniziato Guggenheim Buy
2016-06-13 Iniziato Wedbush Outperform
Mostra tutto

Merus N V Borsa (MRUS) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about Merus N.V. stockMarket-leading profit generation - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Merus N.V. Stock Analysis and ForecastPowerful market insights - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What drives Merus N.V. stock pricePhenomenal trading returns - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Is Merus N.V. a good long term investmentRapidly expanding wealth - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

Merus Shares Soar 3.24% On Positive Cancer Study Update - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Merus NV stock hits all-time high, reaching 62.98 USD - Investing.com

Jul 18, 2025
pulisher
Jul 17, 2025

Merus Shares Surge Amid Promising Cancer Study - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Merus N.V. Advances in Head and Neck Cancer Treatment with Phase 3 Study - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Learn to Evaluate (MRUS) using the Charts - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 17, 2025

Merus N.V. (NASDAQ:MRUS) Shares Sold by Teacher Retirement System of Texas - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

Merus N.V. (NASDAQ:MRUS) Given Average Rating of “Buy” by Analysts - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Why Merus N.V. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How Merus N.V. stock performs during market volatilitySwing Trade Signals - newser.com

Jul 15, 2025
pulisher
Jul 15, 2025

Merus (MRUS) Gets a Buy from H.C. Wainwright - The Globe and Mail

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Merus N.V. stock price move sharplyAlpha Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Insider Selling: Merus N.V. (NASDAQ:MRUS) COO Sells $924,275.00 in Stock - Defense World

Jul 14, 2025
pulisher
Jul 12, 2025

Merus (NASDAQ:MRUS) Upgraded by Wall Street Zen to Hold Rating - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

MRUS Stock Soars 30% in 3 Months After Phase II Cancer Study Success - sharewise.com

Jul 11, 2025
pulisher
Jul 09, 2025

Merus, Bicara Present Promising HNSCC Trial Data at ASCO 2025, Advance Towards Phase III - Insider Monkey

Jul 09, 2025
pulisher
Jun 29, 2025

Merus N.V. (MRUS): A Breakthrough in Oncology with Petosemtamab's ASCO-Backed Potential - AInvest

Jun 29, 2025
pulisher
Jun 26, 2025

Merus N.V.’s Promising Phase 3 Study in Head and Neck Cancer: What Investors Need to Know - TipRanks

Jun 26, 2025
pulisher
Jun 18, 2025

Merus gains after mid-stage trial data for lead asset in head and neck cancer - MSN

Jun 18, 2025
pulisher
Jun 15, 2025

(MRUS) Technical Data - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 14, 2025

Merus N.V.’s SWOT analysis: promising antibody platform drives stock potential - Investing.com India

Jun 14, 2025
pulisher
Jun 13, 2025

Merus N.V.’s SWOT analysis: promising antibody platform drives stock potential By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 11, 2025

Bicara Therapeutics Looks To Reclaim Some Of The Spotlight From Merus (NASDAQ:BCAX) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 10, 2025

The Netherlands: Merus raises US$300m from underwritten public offering - Investors in Healthcare

Jun 10, 2025
pulisher
Jun 08, 2025

Why Merus N.V. (MRUS) Crashed On Wednesday - MSN

Jun 08, 2025
pulisher
Jun 05, 2025

Merus N.V. announces proposed public offering of common shares - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Merus dips 7%, prices $300M stock at $57 per share - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Merus Announces Public Offering of Common Shares - TipRanks

Jun 05, 2025
pulisher
Jun 04, 2025

Merus Raises $300m After ASCO Success - insights.citeline.com

Jun 04, 2025
pulisher
Jun 04, 2025

Sector Update: Health Care Stocks Mixed Premarket Wednesday - marketscreener.com

Jun 04, 2025

Merus N V Azioni (MRUS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):